- Home
- UVV vs QURE Comparison
UVV vs QURE Comparison
Compare UVV & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UVV | QURE |
|---|---|---|
| Founded | 1886 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UVV | QURE |
|---|---|---|
| Price | $53.04 | $40.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | 251.1K | ★ 2.9M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.25% | N/A |
| EPS Growth | N/A | ★ 29.67 |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $2,885,078,000.00 | $13,107,000.00 |
| Revenue This Year | $0.67 | $126.12 |
| Revenue Next Year | $0.10 | $200.43 |
| P/E Ratio | $40.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.19 | $8.73 |
| 52 Week High | $59.38 | $71.50 |
Technical Indicators
Market Signals| Indicator | UVV | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 51.94 |
| Support Level | $51.56 | $39.50 |
| Resistance Level | $54.02 | $50.47 |
| Average True Range (ATR) | 1.02 | 2.49 |
| MACD | 0.12 | -1.21 |
| Stochastic Oscillator | 79.44 | 17.71 |
Price Performance
Historical ComparisonAbout UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Tobacco Operations segment involves procuring and processing flue-cured, burley, dark air-cured, and oriental leaf tobacco for manufacturers of consumer tobacco products and performing related services. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, the Philippines, Germany, and Other Countries, with the majority of revenue from the USA.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.